# OnCo record iteria-biopharma (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/iteria-biopharma/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "iteria-biopharma" ;
  schema:name "Iteria Biopharma"@en ;
  schema:alternateName "ITERIA BIOPHARMA, S.L."@en ;
  schema:description "Iteria Biopharma is a Galician company designing new small-molecule medicines for cancer. Its first, ITR-251, is aimed at prostate cancer that has spread and stopped responding to hormone therapy, and is due to start its first human trial."@en ;
  schema:url <https://onco.cc/companies/iteria-biopharma/>, <https://iteriabiopharma.com/> ;
  schema:dateModified "2026-10-29"^^xsd:date ;
  schema:citation <https://iteriabiopharma.com/>, <https://iteriabiopharma.com/2024/12/04/iteria-biopharma-the-new-galician-biotech-focused-on-the-discovery-of-precision-drugs-for-cancer-treatment/>, <https://iteriabiopharma.com/2026/04/16/iteria-biopharma-closes-a-e5m-seed-round/>, <https://clinicaltrials.gov/study/NCT07870096> ;
  schema:addressCountry "ES" ;
  onco:cancers <https://onco.cc/cancers/prostate-mcrpc/>, <https://onco.cc/cancers/pancreatic/>, <https://onco.cc/cancers/colorectal/>, <https://onco.cc/cancers/nsclc/> ;
  onco:sections <https://onco.cc/fronts/targeted-therapy/> .